Company Registration No. 16409284 (England and Wales)
SPRING HILL PHARMA LIMITED
Unaudited accounts
for the period from 25 April 2025 to 30 April 2026
SPRING HILL PHARMA LIMITED
Unaudited accounts
Contents
SPRING HILL PHARMA LIMITED
Company Information
for the period from 25 April 2025 to 30 April 2026
Director
Sardar Hassan Shabir
Company Number
16409284 (England and Wales)
Registered Office
Saydon Ltd
408 Coventry Road
Small Heath
Birmingham
West Midlands
B10 0UF
England
SPRING HILL PHARMA LIMITED
Statement of financial position
as at 30 April 2026
Cash at bank and in hand
3,661
Creditors: amounts falling due within one year
(201,933)
Net current liabilities
(28,703)
Total assets less current liabilities
289,364
Creditors: amounts falling due after more than one year
(259,000)
Profit and loss account
30,363
Shareholders' funds
30,364
For the period ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the period in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 3 July 2026 and were signed on its behalf by
Sardar Hassan Shabir
Director
Company Registration No. 16409284
SPRING HILL PHARMA LIMITED
Notes to the Accounts
for the period from 25 April 2025 to 30 April 2026
SPRING HILL PHARMA LIMITED is a private company, limited by shares, registered in England and Wales, registration number 16409284. The registered office is Saydon Ltd, 408 Coventry Road, Small Heath, Birmingham, West Midlands, B10 0UF, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Total
Charge for the period
35,151
SPRING HILL PHARMA LIMITED
Notes to the Accounts
for the period from 25 April 2025 to 30 April 2026
5
Tangible fixed assets
Total
6
Average number of employees
During the period the average number of employees was 1.